Key result
ECMO circuit exchange in patients with severe respiratory failure was associated with significant hematological changes, including a 42-fold increase in plasma-free hemoglobin (p < 0.01).
Why the study?
Membrane oxygenator failure during V-V ECMO causes complications, but the underlying mechanisms driving associated hyperfibrinolysis and bleeding are limited.
Does ECMO circuit exchange improve hematological markers in patients with severe respiratory failure on V-V ECMO?
Cohort (n=100)
Does ECMO circuit exchange improve hematological markers in patients with severe respiratory failure on V-V ECMO?
Effect estimate: 42-fold increase
p-value: p=< 0.01
ECMO circuit exchange normalizes progressively deranged hematological markers, supporting its biologic plausibility in preventing complications such as hyperfibrinolysis and clinical bleeding.
Hematological changes around V-V ECMO exchanges remain incompletely defined; hypothesis-generating for hyperfibrinolysis mechanisms and bleeding risk.
Membrane oxygenator failure during venovenous (V-V) extracorporeal membrane oxygenation (ECMO) can lead to life-threatening hypoxia, high replacement costs, and may be associated with a hyperfibrinolytic state and bleeding. The current understanding of the underlying mechanisms that drive this is limited. The primary aim of this study therefore is to investigate the hematological changes that occur before and after membrane oxygenator and circuit exchanges (ECMO circuit exchange) in patients with severe respiratory failure managed on V-V ECMO. We analyzed 100 consecutive V-V ECMO patients using linear mixed-effects modeling to evaluate hematological markers in the 72 hours before and 72 hours after ECMO circuit exchange. A total of 44 ECMO circuit exchanges occurred in 31 of 100 patients. The greatest change from baseline to peak were seen in plasma-free hemoglobin (42-fold increase p < 0.01) and the D-dimer:fibrinogen ratio (1.6-fold increase p = 0.03). Bilirubin, carboxyhemoglobin, D-dimer, fibrinogen, and platelets also showed statistically significant changes ( p < 0.01), whereas lactate dehydrogenase did not ( p = 0.93). Progressively deranged hematological markers normalize more than 72 hours after ECMO circuit exchange, with an associated reduction in membrane oxygenator resistance. This supports the biologic plausibility that ECMO circuit exchange may prevent further complications such as hyperfibrinolysis, membrane failure, and clinical bleeding.
No takes yet. Share an insight, caveat, or question.
Hoffman et al. (2023) conducted a cohort in Severe respiratory failure managed on V-V ECMO (n=100). ECMO circuit exchange vs. Baseline (72 hours before exchange) was evaluated on Hematological changes (plasma-free hemoglobin and D-dimer:fibrinogen ratio) (42-fold increase, p=< 0.01). ECMO circuit exchange in patients with severe respiratory failure was associated with significant hematological changes, including a 42-fold increase in plasma-free hemoglobin (p < 0.01).
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: